BPC 15mg +TB15mg – 30mg (10 vials)

BPC-157 15mg + TB-500 15mg – 30mg – 10 Vials

Product Overview

This combination product is listed as containing BPC-157 and TB-500, two synthetic peptides that have attracted research interest in areas involving tissue biology, cellular signaling, and repair-related processes.

BPC-157 is a synthetic peptide associated with a sequence derived from a protein found in gastric juice. TB-500 is a name commonly used in commercial peptide listings, but its exact identity and relationship to thymosin beta-4 should be verified through supplier documentation.

Research involving these compounds does not establish that this combination is safe or effective for human therapeutic use.

Product Details

• Product Name: BPC-157 + TB-500
• BPC-157 Listed Strength: 15mg
• TB-500 Listed Strength: 15mg
• Combined Listed Amount: 30mg
• Package Quantity: 10 vials
• Product Category: Synthetic Peptide Combination
• Research Areas: Peptide biology and cellular processes
• Manufacturer: Confirm with supplier
• Formulation: Confirm with supplier
• Storage Requirements: Follow verified manufacturer documentation

Scientific Background

BPC-157

BPC-157 is a synthetic peptide investigated primarily in preclinical research. Studies have explored its biological activity in various experimental models, but these findings do not establish clinical benefits or safety in humans.

TB-500

TB-500 is a commercial designation commonly associated with thymosin beta-4-related research. However, commercial products may differ in composition. The exact sequence and ingredient identity should be confirmed before making specific scientific claims.

Product Verification

Before publishing or distributing this product, confirm:

• Whether each vial contains 15mg of BPC-157 and 15mg of TB-500
• Whether the combined 30mg amount applies to each vial
• The exact identity and sequence of the TB-500 ingredient
• Manufacturer identity and product labeling
• Batch identification and available quality documentation
• Storage and handling requirements
• Applicable regulatory status and distribution requirements

Important Safety and Regulatory Information

BPC-157 and TB-500 should be treated as investigational research compounds. Their safety and effectiveness for therapeutic human use have not been established sufficiently to present them as approved treatments.

This description is for product identification and general research information only. It is not medical advice, a dosing guide, or a recommendation for human administration. Do not make unsupported claims about healing, injury recovery, or other clinical benefits. Verify the product’s identity and regulatory status before publication.